Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002873 · ClinicalTrials.gov registry record · Phase 1

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

A Phase 1 study of Breast Cancer, sponsored by Radiation Therapy Oncology Group.

Completed
Registry status
Phase 1
Development phase
20
Study locations

NCT00002873 is a Phase 1 study of Breast Cancer that has completed, run by Radiation Therapy Oncology Group. The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002873, a Phase 1 study of Breast Cancer, has completed, sponsored by Radiation Therapy Oncology Group.

COMPLETED
Registry status
Phase 1
Development phase
20
Study locations

Study Summary

RATIONALE: Radiation therapy may kill any tumor cells remaining after surgery. PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating women who have stage I or stage II breast cancer.

Conditions Studied

Interventions

  • RADIATION brachytherapy

Study Locations (20)

California

  • Providence Saint Joseph Medical Center - Burbank - Burbank
  • Mount Diablo Medical Center - Concord
  • Beckman Research Institute, City of Hope - Duarte
  • California Cancer Center - Fresno
  • Saint Agnes Cancer Center - Fresno
  • Glendale Memorial Hospital and Health Center - Glendale
  • Sutter Health Western Division Cancer Research Group - Greenbrae
  • Loma Linda University Medical Center - Loma Linda
  • Veterans Affairs Medical Center - Long Beach - Long Beach
  • Kaiser Permanente Medical Center - Los Angeles - Los Angeles
  • USC/Norris Comprehensive Cancer Center - Los Angeles

Alabama

  • Veterans Affairs Medical Center - Birmingham - Birmingham
  • University of Alabama Comprehensive Cancer Center - Birmingham
  • Huntsville Hospital System - Huntsville
  • Urology Associates - Mobile AL - Mobile
  • MBCCOP - University of South Alabama - Mobile
  • Alabama Oncology, LLC - Montgomery
  • Radiation Oncology Associates of West Alabama - Tuscallosa

Alaska

  • Providence Cancer Therapy Center - Anchorage

Arizona

  • Arizona Cancer Center - Tucson

Trial Details

FieldValue
Start Date 1997-05
Phase Phase 1

Sponsor

Radiation Therapy Oncology Group

144 total trials

What the Registry Record Tells You About NCT00002873

The ClinicalTrials.gov registry entry for NCT00002873 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which brachytherapy is the first listed.

NCT00002873 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Alabama, Alaska.

Frequently Asked Questions

What is clinical trial NCT00002873 about?

NCT00002873 is a clinical study titled "Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer". RATIONALE: Radiation therapy may kill any tumor cells remaining after surgery. PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating women who have stage I or stage II breast cancer.

What is the current status of trial NCT00002873?

This trial is currently completed. It is a Phase 1 study. The study started on 1997-05.

What conditions does trial NCT00002873 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00002873?

The interventions under investigation include: brachytherapy (RADIATION).

Who is sponsoring clinical trial NCT00002873?

This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002873 being conducted?

This trial has 20 study locations across Alabama, Alaska, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.